
    
      Study drugs: Patients will be randomized a 1:1 rate and open label fashion to two
      interventions: group 1: colistin loading dose followed by colistin infusion iv/8h or group 2:
      meropenem 2 g/iv/ 8 h. The overall treatment time will be a minimum of 8 days.

      Follow-up visits will be performed at baseline, 72 h, 8 days, the end of treatment, and 28
      days from recruitment ICU discharge, hospital discharge or death.
    
  